Last REACH Registration Period Completed

Last REACH Registration Period Completed  (c) Paul Bradbury/Getty Images
Last REACH Registration Period Completed (c) Paul Bradbury/Getty Images

The last registration period for existing chemicals under the EU’s REACH chemicals legislation was completed on May 31. Over the 10-year period, 21 551 substances currently sold on the EU market were registered, according to the European Chemicals Agency, ECHA which administrates the program.

ECHA said altogether 13 620 European companies have now submitted information in nearly 90 000 registrations for chemicals manufactured in or imported to the EU and the European Economic Area (EEA) in volumes of above 1 t/y.

With the REACH regulation, the EU has established a fair and transparent internal market for chemicals with strict safety rules, the Helsinki-based agency said. “This promotes innovation towards safer substances and strengthens EU competitiveness.”

“European industry has assessed and managed the health and environmental risks of its chemicals and sent proof of that to ECHA,” executive director Bjorn Hansen commented.   “Most of the companies,” he said, “managed to register on time, and can already see the benefits: they have a better understanding of the properties and uses of their chemicals, which directly improves safe use in the supply chain.”

Not only Europe benefits from the knowledge collected under REACH, said Hansen.  The EU has become a global role model for chemicals safety. Legislators outside Europe “are inspired by REACH and benefit from the data that is publicly available.” ECHA maintains the world’s largest public regulatory database on chemicals.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.